ITRM היקף יתרות המזומנים של החברה Iterum Therapeutics plc

Iterum Therapeutics plc relies on research centers in the US and Ireland to develop antibiotics targeting resistant infections. The level of cash resources confirms current liquidity status, where the 0.00 mark serves as a key metric. Drug production is fully outsourced to external CMO partners. Meanwhile, the expansion of sales markets for oral medications treating urinary tract infections ensures stable global demand.
פילוחי מדדים פיננסיים ומדדי שוק עבור Iterum Therapeutics (ITRM)

This indicator tracks the volume of highly liquid assets, determining the company's ability to cover operating expenses without incurring external debt. An analysis of the current cash position on GURU.Markets allows for an assessment of the financial stability of Iterum Therapeutics plc (ITRM), which is critical for maintaining complex international antibiotic logistics and minimizing risks when supplying hospitals under regulatory constraints.